Protease inhibitor replacement therapy

This page covers all Protease inhibitor replacement therapy drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Alpha-1 antitrypsin (serum protein replacement), Alpha-1 protease inhibitor (A1PI).

Targets

Alpha-1 antitrypsin (serum protein replacement) · Alpha-1 protease inhibitor (A1PI)

Marketed (2)

• AAT · Rabin Medical Center · Pulmonology / Hepatology
  AAT (Alpha-1 Antitrypsin) is a protease inhibitor that replaces deficient endogenous alpha-1 antitrypsin to protect lung tissue from enzymatic degradation.
• Another Available A1PI · Takeda · Pulmonology / Respiratory
  This drug replaces deficient alpha-1 protease inhibitor (A1PI) protein to prevent progressive lung damage in patients with alpha-1 antitrypsin deficiency.